VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
LFMD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
LFMDLifeMD, Inc.
$4.13$200M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksLFMDBalance Sheet

LifeMD, Inc. (LFMD) Balance Sheet

15Y historyFree accessUpdated daily

The company has significantly improved its financial flexibility by reducing total debt to $6.2 million in 2026Q1, though a tight current ratio of 1.04 leaves minimal buffer for operational volatility.

LFMD Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11
Total Current Assets51.7M51.83M48.73M42.6M11.31M44.92M12.41M2.75M1.61M1.26M789.82K448.47K131.47K450.73K212K128.66K
Cash & Short-Term Investments34.48M36.79M35M33.15M3.96M41.33M9.18M1.11M180.09K141.38K182.56K232.98K75.5K155.06K98.93K33.5K
Cash Only34.48M36.79M35M33.15M3.96M41.33M9.18M1.11M180.09K141.38K182.56K232.98K75.5K155.06K98.93K33.5K
Short-Term Investments0000000000000000
Accounts Receivable9.86M9.31M8.22M5.28M2.83M980.05K997.76K97.45K99.05K128.19K446.99K154.44K14.97K209.47K49.69K36.36K
Days Sales Outstanding14.8617.514.1212.638.693.859.772.854.349.2631.1446.257.6594.5826.9217.84
Inventory3.18M2.77M2.8M2.76M3.7M1.62M1.26M950.06K1.02M707.16K160.27K61.05K41.01K86.19K63.38K58.8K
Days Inventory Outstanding39.3725.7642.4253.372.4132.7952.08137.32189.56173.9730.0689.9486.59173.53184.1588.96
Other Current Assets4.19M2.97M2.67M934.51K687.02K793.19K154.88K442.97K270.01K296.48K000000
Total Non-Current Assets18.43M18.58M23.73M15.88M14.35M5M990.26K699.08K1.01M00043.75K100.72K157.7K214.67K
Property, Plant & Equipment5.06M5.27M7.88M1.07M1.68M1.99M274.44K23.63K000043.75K100.72K157.7K214.67K
Fixed Asset Turnover36.92x36.84x26.96x142.41x70.75x46.76x135.89x527.77x----16.32x8.03x4.27x3.46x
Goodwill0000000000000000
Intangible Assets230.42K262.33K15.85M14.81M12.67M3.02M715.82K675.45K1.01M0000000
Long-Term Investments0000000000000000
Other Non-Current Assets13.14M13.05M000000000000-157.7K0
Total Assets70.12M70.41M72.46M58.48M25.67M49.92M13.4M3.45M2.62M1.26M789.82K448.47K175.22K551.45K369.69K343.33K
Asset Turnover3.13x2.76x2.93x2.61x4.64x1.86x2.78x3.62x3.18x4.00x6.63x2.72x4.08x1.47x1.82x2.17x
Asset Growth %-1.36%-2.83%23.9%127.85%-48.59%272.48%288.92%31.73%107%60.01%76.11%155.95%-68.23%49.16%7.68%-
Total Current Liabilities49.59M41.57M60.26M34.78M31.37M22.83M13.93M3.98M1.19M640.97K1.15M267.48K301.52K325.56K187.1K561.51K
Accounts Payable21.65M14.15M16.01M11.08M10.11M9.06M10.41M3M869K473.49K752.93K167.48K141.32K185.36K187.1K199.34K
Days Payables Outstanding248.2131.43242.78214.07197.61183.75428.72433.34161.08116.48141.22246.72298.42373.17543.63301.58
Short-Term Debt670.83K642.42K8.44M327.6K2.8M63.4K779.13K814.73K247.42K167.48K206.37K100K27.2K40.2K0262.17K
Deferred Revenue (Current)48.97M10.81M14.48M8.83M5.55M1.5M916.88K075.98K-473.49K0-167.48K-274.32K-40.2K00
Other Current Liabilities15.24M15.97M5.11M10.93M576.03K1.66M237.04K109.55K-869K-422.35K-560.68K-167.48K133K000
Current Ratio1.04x1.25x0.81x1.22x0.36x1.97x0.89x0.69x1.35x1.97x0.69x1.68x0.44x1.38x1.13x0.23x
Quick Ratio0.98x1.18x0.76x1.15x0.24x1.90x0.80x0.45x0.49x0.87x0.55x1.45x0.30x1.12x0.79x0.12x
Cash Conversion Cycle-193.97-88.16-186.24-148.14-116.51-147.11-366.88-293.1732.8266.74-80.01-110.54-204.17-105.06-332.56-194.78
Total Non-Current Liabilities5.5M5.68M16.25M18.13M1.6M1.28M292.32K599.98K604K00013.2K30.4K47.6K64.8K
Long-Term Debt5.5M09.89M17.93M000000000000
Capital Lease Obligations17.57M5.68M6.27M73.85K574.14K1.18M192.32K29.98K00000000
Deferred Tax Liabilities000000004K00013.2K30.4K47.6K64.8K
Other Non-Current Liabilities00100K131.25K1.02M100K100K570K600K0000000
Total Liabilities55.09M47.25M76.51M52.91M32.97M24.1M14.22M4.58M1.8M640.97K1.15M267.48K314.72K355.96K234.7K626.31K
Total Debt6.17M6.32M25.1M18.93M4.13M1.85M1.06M844.71K247.42K167.48K206.37K100K27.2K40.2K0262.17K
Net Debt-28.31M-30.46M-9.9M-14.21M168.52K-39.48M-8.11M-261.91K67.32K26.1K23.8K-132.98K-48.3K-114.86K-98.93K228.67K
Debt / Equity0.41x0.27x-3.40x-0.07x--0.30x0.27x-0.55x-0.21x--
Debt / EBITDA-1.20x--------1.04x------
Net Debt / EBITDA5.51x--------0.16x------
Interest Coverage-6.48x-5.64x-7.40x-5.58x-31.10x-17.98x-34.67x-3.80x-5.80x-12.72x-24.16x-3.60x-101.00x-83.33x-136.30x-23.46x
Total Equity15.04M23.16M-4.05M5.57M-7.31M25.82M-821.76K-1.13M819.74K622.84K-361.73K180.99K-139.5K195.49K135K-282.98K
Equity Growth %4876.11%672.42%-172.68%176.19%-128.29%3241.91%27.23%-237.76%31.61%272.19%-299.86%229.74%-171.36%44.81%147.71%-
Book Value per Share0.320.51-0.100.16-0.240.96-0.06-0.110.090.07-0.050.03-0.020.030.02-0.04
Total Shareholders' Equity15.04M23.16M-5.49M3.51M-6.83M26.85M1.35M-988.18K897.7K881.92K-355.17K100.08K-139.5K195.49K135K-282.98K
Common Stock476.33K467.6K422.94K383.59K315.53K307.05K234.34K106.81K457.82K444.93K355.7K320.1K307.3K301.05K289.1K247.29K
Retained Earnings-238.25M-228.6M-236.25M-214.27M-190.56M-141.92M-80.15M-16.59M-12.14M-10.9M-9.69M-8.59M-8.52M-8.06M-7.8M-7.35M
Treasury Stock0-163.7K-163.7K-163.7K-163.7K-163.7K-163.7K-163.7K-163.7K-163.7K-87.05K0000-51.83K
Accumulated OCI00000000000-679.29K-635.54K000
Minority Interest001.44M2.06M-475.55K-1.03M-2.18M-141.06K-77.96K-259.08K-6.55K80.91K0000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetMixed
Cash FlowBurning
Top Statement Risk

High Customer Acquisition Costs

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Balance Sheet Volatility Reflects Instability

As reported in recent financial filings, LifeMD's equity position has fluctuated significantly, swinging from a deficit of $7.7 million in 2024Q3 to a positive $15.0 million by 2026Q1, suggesting that the company's underlying financial foundation remains highly sensitive to operational performance and capital structure adjustments.

The rapid shift from negative to positive equity indicates that the company has likely relied on external financing or equity issuance to stabilize its position rather than organic earnings growth. Investors should monitor whether this trajectory can be sustained without further dilution, as the current balance sheet strength appears contingent on periodic capital injections.

Deleveraging Efforts Improve Financial Flexibility

Based on the company's reported figures, total debt has been reduced from a peak of $25.1 million in 2025Q1 to $6.2 million in 2026Q1, which significantly lowers the interest burden and suggests a strategic shift toward reducing financial leverage amidst a challenging revenue environment.

This reduction in debt is a positive development for the company's risk profile, as it mitigates the threat of insolvency during periods of negative operating cash flow. However, the reliance on debt reduction to manage risk may limit the capital available for the aggressive marketing spend required to drive user growth.

Liquidity Buffers Remain Under Pressure

According to quarterly balance sheet data, the current ratio has hovered near or below 1.0 for several periods, reaching 1.04 in 2026Q1, which indicates that the company maintains a tight liquidity position that leaves little room for operational errors or unexpected spikes in customer acquisition costs.

The narrow current ratio suggests that the company's ability to meet short-term obligations is heavily dependent on the timely conversion of its current assets into cash. Given the ongoing revenue contraction, this liquidity profile warrants close monitoring to ensure that the company does not face a working capital crunch.

Goodwill and Intangibles Mask Risks

As disclosed in financial statements, the company's goodwill and intangible assets have fluctuated, with a notable drop from $16.7 million in 2025Q2 to $230.4K in 2026Q1, which may indicate significant impairment charges or a strategic revaluation of previously acquired assets that were not delivering expected returns.

The volatility in these non-current assets suggests that the company's historical M&A strategy may have been overly optimistic regarding the value of acquired entities. Investors should be wary of further write-downs, as these adjustments directly impact the equity base and could signal that the company is struggling to integrate its disparate business segments effectively.

LFMD — Frequently Asked Questions

Quick answers to the most common questions about buying LFMD stock.

What are the total assets of LifeMD, Inc. (LFMD)?

As of 2025, LifeMD, Inc. (LFMD) had total assets of $70.4M including $51.8M in current assets.

How much debt does LifeMD, Inc. (LFMD) have?

LifeMD, Inc. (LFMD) carries total debt of $6.3M, offset by $36.8M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of LifeMD, Inc.?

LifeMD, Inc. (LFMD) has total shareholders' equity (book value) of $23.2M ($0.51 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is LifeMD, Inc.'s current ratio and liquidity?

LifeMD, Inc. (LFMD) reported a current ratio of 1.25x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.